GlassScriptPhysician profile
Nnamdi A Uhegwu
NPI 1861809717
$923.19
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $16.72 · 2021: $133 · 2022: $118 · 2023: $196 · 2024: $56.25 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $324.09 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Alexion Pharmaceuticals, INC. | $154.28 | 2019-2025 | Ultomiris, Soliris |
| Eisai INC. | $86.24 | 2019-2025 | |
| Csl Behring | $79.39 | 2019 | |
| Amgen INC. | $44.24 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $28.83 | 2024 | Rytary |
| Tanabe Pharma America, INC. | $27.68 | 2019 | |
| Averitas Pharma INC. | $22.41 | 2025 | Qutenza |
| Avion Pharmaceuticals | $20.53 | 2022 | |
| Spr Therapeutics, INC | $19.21 | 2023 | Sprint Pns System |
| Argenx US, INC. | $17.80 | 2023 | |
| Arbor Pharmaceuticals, INC. | $16.72 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.18 | 2022 | |
| Genzyme Corporation | $14.44 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $13.64 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $13.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.14 | 2021 | |
| Allergan, INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nnamdi Uhegwu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.